PM

Parth Mayurbhai Shah

Active Director Director DIN 03152390
DIN 03152390 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Dec 2010
Shareholding value •••• Premium profile

About Parth Mayurbhai Shah

Data last updated:

Parth Mayurbhai Shah is a Director at Antila Lifesciences Private Limited (since 2010), Director at Antila Wellness Private Limited (since 2016) and Director at Hublore Healthcare Private Limited (since 2014), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹109 Cr; the largest is Antila Lifesciences Private Limited at ₹103 Cr (FY 2025). Earlier, Parth Mayurbhai Shah was an Additional Director at Endurance Healthcare Private Limited (2015–2016).

DIN 03152390
Primary Designation Director
Industry Pharma
First Appointment 21 Dec 2010
Oldest Company Age 15 yrs
Largest company Antila Lifesciences Private Limited · ₹103 Cr (FY 2025)
Combined revenue ₹109 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Antila Lifesciences Private Limited U24230GJ2010PTC063306
Director21 Dec 20102010₹103 Cr (FY 2025)Active
Antila Wellness Private Limited U85100GJ2013PTC077035
Director20 Sep 20162013₹3.46 Cr (FY 2025)Active
Hublore Healthcare Private Limited U33110GJ2014PTC081441
Director08 Dec 20142014₹1.87 Cr (FY 2024)Active
Enclave Llp ACS-7836
Partner05 Feb 20262025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Endurance Healthcare Private Limited U24231GJ1999PTC035574
Additional Director25 Mar 20151999₹8.01 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Antila Lifesciences Private Limited
Hublore Healthcare Private Limited
Antila Wellness Private Limited
Enclave Llp
Premium access

Shareholding and investment profile for Parth Mayurbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parth Mayurbhai Shah

Parth Mayurbhai Shah currently holds 4 directorships: Antila Lifesciences Private Limited (Director, since 21 Dec 2010, revenue ₹103 Cr (FY 2025)); Antila Wellness Private Limited (Director, since 20 Sep 2016, revenue ₹3.46 Cr (FY 2025)); Hublore Healthcare Private Limited (Director, since 08 Dec 2014, revenue ₹1.87 Cr (FY 2024)); Enclave Llp (Partner, since 05 Feb 2026).

Parth Mayurbhai Shah was first appointed on 21 Dec 2010 as Director at Antila Lifesciences Private Limited. The most recent appointment on record is 05 Feb 2026 at Enclave Llp.

The 3 current companies of Parth Mayurbhai Shah that report revenue have a combined latest revenue of ₹109 Cr: Antila Lifesciences Private Limited ₹103 Cr (FY 2025); Antila Wellness Private Limited ₹3.46 Cr (FY 2025); Hublore Healthcare Private Limited ₹1.87 Cr (FY 2024).

Parth Mayurbhai Shah held 1 earlier board appointment: Endurance Healthcare Private Limited (Additional Director, 25 Mar 2015 to 31 Mar 2016).

The current boards of Parth Mayurbhai Shah's companies include Rutwa Vijaykumar Shah (Antila Lifesciences Private Limited), Sanjay Jashwantlal Shah (Antila Lifesciences Private Limited), Rahil Sanjaybhai Shah (Antila Wellness Private Limited), Vishad Urvish Jhaveri (Hublore Healthcare Private Limited), Jaluk Rameshbhai Patel (Enclave Llp), Maharsh Ashishkumar Patel (Enclave Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available